590 results on '"Kwee, Ivo"'
Search Results
2. Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing
3. NLRC5 promotes transcription of BTN3A1-3 genes and Vγ9Vδ2 T cell-mediated killing
4. Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potential
5. Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models
6. Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potential
7. Dynamics in protein translation sustaining T cell preparedness
8. PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine
9. A Comparison of Heuristic Methods for the Prize-Collecting Steiner Tree Problem and Their Application in Genomics
10. A Fast Prize-Collecting Steiner Forest Algorithm for Functional Analyses in Biological Networks
11. BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance
12. Gradient-based Reinforcement Planning in Policy-Search Methods
13. Market-Based Reinforcement Learning in Partially Observable Worlds
14. Towards a Bayesian framework for optical tomography
15. Myc controls NK cell development, IL-15-driven expansion, and translational machinery
16. Data from Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α–STAT3 Axis
17. Supplementary Figure from Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α–STAT3 Axis
18. Supplementary Data from Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α–STAT3 Axis
19. Supplemental Table S4 from The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
20. Supplemental Figures S1-2 from The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
21. Table S5 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
22. Table S2 from PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
23. Supplemental Figures S6 from The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
24. Supplemental Table S2-3 from The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
25. Supplemental Figures S3-5 from The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
26. Supplementary figures, table legends, Table S1, S9 from PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
27. A divide and conquer matheuristic algorithm for the Prize-collecting Steiner Tree Problem
28. Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts
29. Correction to: cuRnet: an R package for graph traversing on GPU
30. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
31. Myc controls IL-15-driven expansion and translational machinery of NK cells
32. Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α–STAT3 Axis
33. Bayesian Joint Estimation of CN and LOH Aberrations
34. cuRnet: an R package for graph traversing on GPU
35. Apyrase-mediated amplification of secretory IgA promotes intestinal homeostasis
36. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma
37. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
38. Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma
39. Apyrase-mediated amplification of secretory IgA promotes intestinal homeostasis
40. Apyrase-mediated amplification of secretory IgA promotes intestinal homeostasis
41. Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma
42. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
43. Assessment of the Antiproliferative Activity of a BET Bromodomain Inhibitor as Single Agent and in Combination in Non-Hodgkin Lymphoma Cell Lines
44. Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines
45. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
46. Hierarchical clustering analysis of pathologic and molecular data identifies prognostically and biologically distinct groups of colorectal carcinomas
47. Protein Expression of AEBP1, MCM4, and FABP4 Differentiate Osteogenic, Adipogenic, and Mesenchymal Stromal Stem Cells
48. metaLINCS: an R package for meta-level analysis of LINCS L1000 drug signatures using stratified connectivity mapping
49. IL-1α secreted by subcapsular sinus macrophages promotes melanoma metastasis in the sentinel lymph node by upregulating STAT3 signaling in the tumor
50. The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.